Molecular mechanisms involved in NSAID-induced gastropathy

Journal of Clinical Gastroenterology

Volumn 27, Issue SUPPL. 1, 1998, Pages

  Morise, Zenichi ^a   Grisham, Matthew B ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Adhesion molecules; Inflammation; Neutrophils; NF B; Proteasome

Indexed keywords

CD18 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; NONSTEROID ANTIINFLAMMATORY AGENT; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

CELL ADHESION; CONFERENCE PAPER; LEUKOCYTE ACTIVATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH MUCOSA; STOMACH MUCOSA INJURY; TRANSCRIPTION REGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL ADHESION; INDOMETHACIN; LEUKOCYTES; MICE; MODELS, MOLECULAR; RATS; STOMACH DISEASES;

EID: 0032433179     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199800001-00014     Document Type: Conference Paper

References (37)

1. Ligumsky M, Sestieri M, Karmeli F, Zimmerman J, Okon E, Rachmilewitz D. Rectal administration of nonsteroidal anti-inflammatory drugs. Gastroenterology 1990;98:1245-9.
2. Langenbach R, Morham SG, Tiano HF, Loftin CD, Ghanayem BI, Chulada PC, Mahler JF, Lee CA, Goulding EH, Kluckman KD, Kim HS, Smithies O. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 1995;83:483-92.
3. Wallace J, Keenan C, Granger DN. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am J Physiol 1990;259 (Gastrointest. Liver Physiol. 22):G462-7
4. Wallace J, Arfors KE, McKnight GW. A monoclonal antibody against the CD18 leukocyte adhesion molecule prevents indomethacin-induced gastric damage in the rabbit. Gastroenterology 1991;100:878-83.
5. Wallace J, McKnight GW, Miyasaka M, Tamatani T, Paulson J, Anderson DC, Granger DN, Kubes P. Role of endothelial adhesion molecules in NSAID-induced gastric mucosal injury. Am J Physiol 1993;265 (Gastrointest. Liver Physiol. 28):G993-8.
6. Panés J, Perry MA, Anderson DC, Manning A, Leone B, Cepinskas G, Rosenbloom CL, Miyasaka M, Kvietys PR, Granger DN. Regional differences in constitutive and induced ICAM-1 expression in vivo. Am J Physiol 1995;269 (Heart Cire Physiol 38):H1955-64.
7. Komatsu S. Panés J, Russell JM, et al. Effects of chronic arterial hypertension on constitutive and induced ICAM-1 expression in vivo. Hypertension 1997;29:P283-89.
8. Morise Z, Komatsu S, Fuseler JW, et al. ICAM-1 and P-selectin expression in a model of NSAID-induced gastropathy. Am J Physiol 1998;274:G246-52.
9. Vaananen PM, Meddings JB, Wallace JL. Role of oxygen-derived free radicals in indomethacin-induced gastric injury. Am J Physiol 1991;261:G470-5.
10. Kitahora T, Guth PH. Effect of aspirin plus hydrochloric acid on the gastric mucosal microcirculation. Gastroenterology 1987;93:810-7.
11. Santucci L, Fiorucci S, Giansanti M, Brunori PM, Di Matteo FM, Morelli A. Pentoxifylline prevents indomethacin induced acute gastric mucosal damage in rats: role of tumor necrosis factor alpha. Gut 1994;35:909-15.
12. Appleyard CB, McCafferty D-M, Tigley AW, Swain MG, Wallace JL. Tumor necrosis factor mediation of NSAID-induced gastric damage: role of leukocyte adherence. Am J Physiol 1996;270:G42-8.
13. 4 stimulates polymorphonuclear leukocyte adhesion to cultured vascular endothelial cells. J Clin Invest 1984;74:1552-5.
14. Rioux KP, Wallace JL. Mast cells do not contribute to non-steroidal anti-inflammatory drug-induced mucosal injury in rodents. Aliment Pharmacol Ther 1996;10:173-80.
15. Vaananen PM, Keenan CM, Grisham MB, Wallace JL. Pharmacological investigation of the role of leukotrienes in the pathogenesis of experimental NSAID gastropathy. Inflammation 1992;16:227-40.
16. Rainsford KD. Leukotrienes in the pathogenesis of NSAID-induced gastric and intestinal mucosal damage. Agents Actions 1993;39:C24-6.
17. Asako H, Kubes P, Wallace J, Gaginella T, Wolf RE, Granger DN. Indomethacin-induced leukocyte adhesion in mesenteric venules: role of lipoxygenase products. Am J Physiol 1992; 262:G903-8.
18. Asako H, Kubes P, Wallace J, Wolf RE, Granger DN. Modulation of leukocyte adhesion in rat mesenteric venules by aspirin and salicylate. Gastroenterology 1992;103:146-52.
19. Kobayashi K, Fukuda T, Higuchi K, Nakamura H, Arakawa T. Role of leukotrienes in indomethacin-induced mucosal damage in rats. J Clin Gastroenterol 1993;17(Suppl 1):S11-4.
20. Baeuerle PA, Henkle T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994;12:141-79.
21. Kopp E, Ghosh S. NF-κB and Rel proteins in an innate immunity. Adv Immunol 1994;58:1-27.
22. Baeuerle PA, Baltimore D. IκB: a specific inhibitor of the NF-κB transcription factor. Science 1988;242:540-6.
23. Osborn L, Kunkel S, Nabel GJ. TNF-α and interleukin-1 stimulate the human immunodeficiency virus enhancer by activation of the NF-κB. Proc Natl Acad Sci USA 1989;86:2336-40.
24. Iwasaki T, Uehara Y, Graves L, Rachie N, Bomsztyk K. Herbimycin A blocks IL-1 induced NFκB DNA-binding activity in lymphoid cell lines. FEBS Lett 1992;298:240-4.
25. Schreck R, Albermann K, Baeuerle PA. NF-κB: an oxidative stress responsive transcription factor of eukaryotic cells. Free Radical Res Commun 1992;17:221-37.
26. Muller JM, Ziegler-Heitbrock HW, Baeuerle PA. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 1993;187:233-56.
27. Stoltz RA, Abraham NG, Schwartzman ML. The role of NFKB in the angiogenic response of coronary microvessel endothelial cells. Proc Natl Acad Sci USA 1996;93:2832-7.
28. Camandola S, Leonarduzzi G, Musso T, et al. Nuclear factor κB is activated by arachidonic acid but not by eicosapentaenoic acid. Biochem Biophys Res Commun 1996;229:643-7.
29. Beg AA, Finco TS, Nanternet PV, Baldwin AS. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I-κB. Mol Cell Biol 1993;13:3301-10.
30. Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U. Control of IκB-α proteolysis by site-specific, signal induced phosphorylation. Science 1995;267:1485-8.
31. Chen ZJ, Parent L, Maniatis T. Site-specific phosphorylation of IκB-α by a novel ubiquitination-dependent protein kinase activity. Cell 1996;84:853-62.
32. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NFκB and cytokine-inducible enhancers. FASEB J 1995;9:899-909.
33. Laio WS, Lu SY, Huang J, Li L, Bing Z. Transcriptional factors as targets of cytokine signals. Ann NY Acad Sci 1995; 762:238-50.
34. Xie QW, Kashiwabara Y, Nathan C. Role of the transcription factor NFκB/Rel in induction of nitric oxide synthase. J Biol Chem 1994;269:4705-8.
35. Adams J, Stein R. Novel inhibitors of the proteasome and their therapeutic uses in inflammation. Annu Rev Med Chem 1996;31:279-88.
36. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T. The ubiquitin-proteasomc pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 1994;78:773-85.
37. Traenckner EB, Wilk S, Baeuerle PA. A proteasome inhibitor prevents the activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa-B-alpha that is still bound to NF-kappa B. EMBO J 1994;13:5433-41.